Professor of Surgery
University of California, San Francisco
Professor of Surgery
University of California, San Francisco
San Francisco, California
Session Moderator
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY AND STENTS (UNCOATED AND COATED)
Presenter
SESSION 23: GENERALITIES IN THE TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND THEIR MEDICAL TREATMENT: SOME NEW CONCEPTS
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON PACLITAXEL TOXICITY, RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON PACLITAXEL TOXICITY, RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Presenter
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Presenter
SESSION 78: CAROTID ARTERY THERAPY STARS AND LATEST TRENDS
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY AND STENTS (UNCOATED AND COATED)
Presenter
SESSION 23: GENERALITIES IN THE TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND THEIR MEDICAL TREATMENT: SOME NEW CONCEPTS
Use Of Intraoperative Pedal Duplex To Detect Embolization During Complex Lower Extremity Revascularization: How To Do It, What Are The Causes And How To Prevent It
7:34 AM - 7:39 AM
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON PACLITAXEL TOXICITY, RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Increased Amputation Rates From Use Of Paclitaxel Coated Devices May Be Real Or A Methodological Artifact: Other Paclitaxel Coating Effects Like Embolization Or Post Atherectomy Aneurysm Formation Deserve Further Study
10:18 AM - 10:23 AM
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON PACLITAXEL TOXICITY, RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Long-Term Results Of An RCT Comparing SurVeil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating Fem-Pop Lesions: From The TRANSCEND Trial: How Do The Two Devices Differ
10:36 AM - 10:41 AM
Presenter
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
What Presently Defines A No Option Or Desert Foot Before Or After Failed Endo Or Open Treatments: Can Better Arterial Imaging Help And How To Do It
1:00 PM - 1:05 PM
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
New 3-Year Results In >1000 Patients From The Lutonix SAFE Registry Demonstrate The Advantages Of The Lutonix DCB (BD) In Specific Patient Subgroups
2:48 PM - 2:53 PM
Presenter
SESSION 78: CAROTID ARTERY THERAPY STARS AND LATEST TRENDS
TCAR Is Better Than True Percutaneous Carotid Stenting: Myth Or Reality
11:27 AM - 11:34 AM
VASCULAR FELLOWS & RESIDENTS CAREER DEVELOPMENT PROGRAM
FRIDAY, NOVEMBER 21, 2025
AMERICAS HALL 1 NORTH, 3RD FLOOR
PRESENTER
11:30 A.M. – 11:38 A.M.
Balancing Your Practice With Industry Relationships – From A Physician's Viewpoint
FRIDAY, NOVEMBER 21, 2025
AMERICAS HALL 1 NORTH, 3RD FLOOR
PRESENTER
11:30 A.M. – 11:38 A.M.
Balancing Your Practice With Industry Relationships – From A Physician's Viewpoint